Consistent with our expectations, the AAV-STAT5A-MI group exhibited significantly lower HW/BW and LW/BW ratios compared to the control group (AAV-NC-MI), indicating reduced cardiac hypertrophy and pulmonary congestion (Figure 8D). The gene discussed is STAT5A; the disease is cardiac hypertrophy.